Aurobindo Pharma gets final USFDA nod for gastro reflux drug
Aurobindo Pharma has received final approval from the USFDA to manufacture and market pantoprazole sodium for injections, used for the treatment of gastroesophageal reflux disease, in the American market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Acid Reflux | Biotechnology | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Pantoprazole | Pharmaceuticals | Protonix